2. Fard N, Saffari A, Emami G, et al.Acute respiratory distress syndrome induction by pulmonary ischemia-reperfusion injury in large animal models.J Surg Res, 2014, 189:274-284.
16. Geddings JE, Mackman N.Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.Blood, 2013, 122:1873-1880.
[4]
17. Amabile N, Rautou PE, Tedgui A, et al.Microparticles:key protagonists in cardiovascular disorders.Semin Thromb Hemost, 2010, 36:907-916.
[5]
18. Owens APⅢ, Mackman N.Microparticles in hemostasis and thrombosis.Circ Res, 2011, 108:1284-1297.
[6]
19. Qiu Q, Xiong W, Yang C, et al.Lymphocyte-derived microparticles induce bronchial epithelial cells' pro-inflammatory cytokine production and apoptosis.Mol Immunol, 2013, 55:220-230.
21. Takahashi T, Kobayashi S, Fujino N, et al.Increased circulating endothelial microparticles in COPD patients:a potential biomarker for COPD exacerbation susceptibility.Thorax, 2012, 67:1067-1074.
[9]
22. Takahashi T, Kobayashi S, Fujino N, et al.Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro.Exp Lung Res, 2013, 39:155-161.
[10]
23. Cerri C, Chimenti D, Conti I, et al.Monocyte/macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells.J Immunol, 2006, 177:1975-1980.
[11]
24. van der Poll T.Tissue factor as an initiator of coagulation and inflammation in the lung.Crit Care, 2008, 12 Suppl 6:S3.
[12]
27. Looney MR, Nguyen JX, Hu Y, et al.Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.J Clin Invest, 2009, 119:3450-3461.
[13]
31. Brown GT, McIntyre TM.Lipopolysaccharide signaling without a nucleus:kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles.J Immunol, 2011, 186:5489-5496.
[14]
33. Maruyama K, Morishita E, Sekiya A, et al.Plasma levels of platelet-derived microparticles in patients with obstructive sleep apnea syndrome.J Atheroscler Thromb, 2012, 19:98-104.
[15]
1. The ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al.Acute respiratory distress syndrome:the Berlin Definition.JAMA, 2012, 307:2526-2533.
[16]
4. McVey M, Tabuchi A, Kuebler WM.Microparticles and acute lung injury.Am J Physiol Lung Cell Mol Physiol, 2012, 303:L364-L381.
[17]
5. Jy W, Horstman LL, Ahn YS.Microparticle size and its relation to composition, functional activity, and clinical significance.Semin Thromb Hemost, 2010, 36:876-880.
[18]
6. Hargett LA, Bauer NN.On the origin of microparticles:From "platelet dust" to mediators of intercellular communication.Pulm Circ, 2013, 3:329-340.
[19]
7. Lacroix R, Dubois C, Leroyer AS, et al.Revisited role of microparticles in arterial and venous thrombosis.J Thromb Haemost, 2013, 11 Suppl 1:24-35.
[20]
8. Wu ZH, Ji CL, Li H, et al.Membrane microparticles and diseases.Eur Rev Med Pharmacol Sci, 2013, 17:2420-2427.
[21]
9. Chaar V, Romana M, Tripette J, et al.Effect of strenuous physical exercise on circulating cell-derived microparticles.Clin Hemorheol Microcirc, 2011, 47:15-25.
[22]
10. Chironi GN, Boulanger CM, Simon A, et al.Endothelial microparticles in diseases.Cell Tissue Res, 2009, 335:143-151.
[23]
11. Guervilly C, Lacroix R, Forel JM, et al.High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome.Crit Care, 2011, 15:R31.
13. Montoro-García S, Shantsila E, Marín F, et al.Circulating microparticles:new insights into the biochemical basis of microparticle release and activity.Basic Res Cardiol, 2011, 106:911-923.
[26]
14. Diamant M, Tushuizen ME, Sturk A, et al.Cellular microparticles:new players in the field of vascular disease? Eur J Clin Invest, 2004, 34:392-401.
[27]
15. Herring JM, McMichael MA, Smith SA.Microparticles in health and disease.J Vet Intern Med, 2013, 27:1020-1033.
[28]
25. Fudala R, Krupa A, Stankowska D, et al.Does activation of the FcγRⅡa play a role in the pathogenesis of the acute lung injury/acute respiratory distress syndrome? Clin Sci(Lond), 2010, 118:519-526.
[29]
26. Dong H, Li J, Lv Y, et al.Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase.BMC Immunol, 2013, 14:25.
[30]
28. Bozza FA, Shah AM, Weyrich AS, et al.Amicus or adversary:platelets in lung biology, acute injury, and inflammation.Am J Respir Cell Mol Biol, 2009, 40:123-134.
[31]
29. Jy W, Mao WW, Horstman L, et al.Platelet microparticles bind, activate and aggregate neutrophils in vitro.Blood Cells Mol Dis, 1995, 21:217-231.
[32]
30. Lo SC, Hung CY, Lin DT, et al Involvement of platelet glycoprotein Ib in platelet microparticle mediated neutrophil activation.J Biomed Sci, 2006, 13:787-796.
[33]
32. Barry OP, Pratico D, Lawson JA, et al.Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.J Clin Invest, 1997, 99:2118-2127.
[34]
34. Jy W, Ricci M, Shariatmadar S, et al.Microparticles in stored red blood cells as potential mediators of transfusion complications.Transfusion, 2011, 51:886-893.
[35]
35. Zhou L, Qi XL, Xu MX, et al.Microparticles:new light shed on the understanding of venous thromboembolism.Acta Pharmacol Sin, 2014, 35:1103-1110.
[36]
36. Densmore JC, Signorino PR, Ou J, et al.Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury.Shock, 2006, 26:464-471.
